RE: SHTG news should be today. Put "Clopidogrel" in search31 Oct 2024 09:05
The Scottish Health Technologies Group (SHTG) has been asked to review the evidence for clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack (TIA). Draft diagnostics guidance from NICE (2024) recommends offering genotype testing to people who are being considered for clopidogrel after having an ischaemic stroke or TIA. This SHTG assessment will summarise the NICE guidance and capture additional evidence relevant to decision making in Scotland (for example, local data, patient views, and cost implications).